Design of TAT-Conjugated Bowman–Birk Trypsin Inhibitor Peptides with Enhanced Antimicrobial and Antiproliferative Activities
Biomolecules · 30.03.2026 · 16 (4) · 511
DOI: 10.3390/biom16040511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 30.03.2026. Verfasst von Ying Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Province Key Laboratory of New Drugs and Chinese Medicine Foundation Research, School of Pharmacy, Shaanxi University of Chinese Medicine, Xi…. Hauptthemen laut MEDLINE: Antineoplastic Agents, tat Gene Products, Human Immunodeficiency Virus, Anti-Infective Agents, Trypsin Inhibitor, Bowman-Birk Soybean. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cell-penetrating peptide (CPP) conjugation represents a promising strategy for enhancing the biological activity of therapeutic peptides. In this study, three analogues were designed by conjugating the trypsin inhibitory loop (TIL) derived from a Bowman–Birk-type inhibitor with the transactivator of transcription (TAT) peptide to improve their bioactivity. All TAT-TIL conjugates exhibited significantly enhanced antimicrobial activity compared with the parent peptide. Notably, the analogue containing a glycine linker (-GG-) showed further improvement in antiproliferative activity against cancer cells, indicating the potential role of linker design in optimizing peptide function. All analogues exhibited low hemolytic activity at the highest tested concentrations, although increased cytotoxicity toward normal HaCaT cells was observed, suggesting the need for further optimization of selectivity. Interestingly, comparable antimicrobial activities were observed regardless of protease inhibitory capacity, indicating that protease inhibition is not essential for the enhanced biological effects. Overall, TAT conjugation significantly improves the biological activity of Bowman–Birk-type inhibitor-derived peptides, and the incorporation of a glycine linker further enhances their functional properties. These findings support CPP-mediated peptide modification as an effective strategy for developing potential antimicrobial and anticancer peptide candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shaanxi Province Key Laboratory of New Drugs and Chinese Medicine Foundation Research, School of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an 712046, China.
- Natural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK.
ORCID-Profile: Tao Wang, Xiaoling Chen, Lei Wang, Mei Zhou, Tianbao Chen
Zitieren
APA
Wang, Y., Jiang, Y., Wang, T., Chen, X., Wang, L., Zhou, M., Burrows, J. F., Chen, T., Zhang, X., & Li, N. (2026). Design of TAT-Conjugated Bowman–Birk Trypsin Inhibitor Peptides with Enhanced Antimicrobial and Antiproliferative Activities. Biomolecules, 16(4), 511. https://doi.org/10.3390/biom16040511
Vancouver
Wang Y, Jiang Y, Wang T, Chen X, Wang L, Zhou M, et al. Design of TAT-Conjugated Bowman–Birk Trypsin Inhibitor Peptides with Enhanced Antimicrobial and Antiproliferative Activities. Biomolecules. 2026;16(4):511. doi:10.3390/biom16040511
BibTeX
@article{Wang2026,
author = {Wang, Ying and Jiang, Yangyang and Wang, Tao and Chen, Xiaoling and Wang, Lei and Zhou, Mei and Burrows, James F and Chen, Tianbao and Zhang, Xiaofei and Li, Na},
title = {Design of TAT-Conjugated Bowman–Birk Trypsin Inhibitor Peptides with Enhanced Antimicrobial and Antiproliferative Activities},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {4},
pages = {511},
doi = {10.3390/biom16040511}
}
EUVIMED